Brooklyn based kosher market to open at closed former Stop and Shop HOWELL, N.J. — Moisha’s Discount Supermarket, a Brooklyn-based grocery chain, is opening a new location on Route 9 in Howell, filling the space vacated by Stop & Shop after the company closed…
Children’s Hospital of Philadelphia Celebrates 26th Annual Fetal Surgery Family Reunion at the Philadelphia Zoo
Bausch + Lomb Announces Scientific Data on Latest Biotrue® Products to be Presented at American Optometric Association’s Optometry’s Meeting
NEW YORK COMMUNITY BANK TO ELIMINATE NON-SUFFICIENT FUND FEES; TO ROLL OUT EARLY PAY PRODUCT DURING THIRD QUARTER
US Navy Veterans Lung Cancer Advocate Now Urges a Navy Veteran-Person Who Now Has Lung Cancer to Call the Lawyers at Danziger & De Llano If They Had Navy-Workplace Exposure to Asbestos Before 1982-Compensation May Exceed $100,000
The Vitamin Shoppe Partners with Baranova27 to Donate over Two Tons of Protein Bars and Nutritious Snacks to Communities Impacted by the War in Ukraine
HSS to Honor Renowned Sports Medicine Surgeon David W. Altchek, MD, and Philanthropist Andreas C. Dracopoulos at The 2022 Tribute Dinner
Mohegan Appoints Heather Menzano as Vice President, Web Communications to Spearhead Digital Marketing Communications and Growth
Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English
CytoSorbents s’associe à Nikkiso pour assurer la distribution de la pompe à sang d’hémoperfusion PureADJUST et de ses consommables dans 14 pays USA – English Deutschland – Deutsch España – español France – Français
New HSS Study Defines Disease Characteristics for Patients with Undifferentiated Connective Tissue Disease
RxBIO launches NeoGen Plasma Skin Rejuvenation in the USA – NeoGen Plasma brings a unique solution to treat the whole skin architecture
Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English Deutschland – Deutsch
Jubilant Therapeutics Inc. berichtet auf der Jahrestagung 2022 der American Society of Clinical Oncology (ASCO) über die Entwicklung oral verfügbarer und ins Gehirn eindringender niedermolekularer PD-L1-Inhibitoren Deutschland – Deutsch USA – English France – Français
CytoSorbents s’associe à Nikkiso pour assurer la distribution de la pompe à sang d’hémoperfusion PureADJUST et de ses consommables dans 14 pays France – Français USA – English Deutschland – Deutsch España – español
Cambrex fait l’acquisition du leader européen de stockage de stabilité Q1 Scientific France – Français USA – English USA – English Deutschland – Deutsch Latin America – español Brazil – Português